GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » Selling, General, & Admin. Expense

VGI Health Technology (XNEC:VTL) Selling, General, & Admin. Expense : A$ Mil (TTM As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. VGI Health Technology's selling, general, & admin. expense for the six months ended in . 20 was A$0.00 Mil. VGI Health Technology does not have enough years/quarters to calculate its selling, general, & admin. expense for the trailing twelve months (TTM) ended in . 20.


VGI Health Technology Selling, General, & Admin. Expense Historical Data

The historical data trend for VGI Health Technology's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology Selling, General, & Admin. Expense Chart

VGI Health Technology Annual Data
Trend
Selling, General, & Admin. Expense

VGI Health Technology Semi-Annual Data
Selling, General, & Admin. Expense

Competitive Comparison of VGI Health Technology's Selling, General, & Admin. Expense

For the Biotechnology subindustry, VGI Health Technology's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VGI Health Technology's Selling, General, & Admin. Expense Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VGI Health Technology's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where VGI Health Technology's Selling, General, & Admin. Expense falls into.



VGI Health Technology Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.


VGI Health Technology  (XNEC:VTL) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


VGI Health Technology Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


VGI Health Technology (XNEC:VTL) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003
VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines